Replies to post #74 on TScan Therapeutics Inc (TCRX)

[jondoeuk]

Not sure if these TIP presentations include any trial data.

It might contain preliminary safety and/or biomarker data. Interim clinical data for the program is expected by the end of the year, so maybe ASH.

An update on the Novartis collaboration would be appropriate, imo, since, if i am not mistaken, that was to end this past March 31/23.

I agree, but we might have to wait for a filing.